These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1357650)
1. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents. Guarini L; Graham GM; Jiang H; Ferrone S; Zucker S; Fisher PB Pigment Cell Res; 1992; Suppl 2():123-31. PubMed ID: 1357650 [TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells. Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons. Graham GM; Guarini L; Moulton TA; Datta S; Ferrone S; Giacomini P; Kerbel RS; Fisher PB Cancer Immunol Immunother; 1991; 32(6):382-90. PubMed ID: 1672507 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons. Leon JA; Gutierrez MC; Jiang H; Estabrook A; Waxman S; Fisher PB Cancer Immunol Immunother; 1992; 35(5):315-24. PubMed ID: 1356626 [TBL] [Abstract][Full Text] [Related]
5. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979 [TBL] [Abstract][Full Text] [Related]
7. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Lin JJ; Jiang H; Fisher PB Gene; 1998 Jan; 207(2):105-10. PubMed ID: 9511750 [TBL] [Abstract][Full Text] [Related]
8. Regulation of mda-7 gene expression during human melanoma differentiation. Madireddi MT; Dent P; Fisher PB Oncogene; 2000 Mar; 19(10):1362-8. PubMed ID: 10713678 [TBL] [Abstract][Full Text] [Related]
10. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970 [TBL] [Abstract][Full Text] [Related]
11. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. Fisher PB; Prignoli DR; Hermo H; Weinstein IB; Pestka S J Interferon Res; 1985; 5(1):11-22. PubMed ID: 3989332 [TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Kang D; Jiang H; Wu Q; Pestka S; Fisher PB Gene; 2001 Apr; 267(2):233-42. PubMed ID: 11313150 [TBL] [Abstract][Full Text] [Related]
13. Transduction of retinoic acid and gamma-interferon signal for intercellular adhesion molecule-1 expression on human tumor cell lines: evidence for the late-acting involvement of protein kinase C inactivation. Bouillon M; Audette M Cancer Res; 1993 Feb; 53(4):826-32. PubMed ID: 8094032 [TBL] [Abstract][Full Text] [Related]
14. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248 [TBL] [Abstract][Full Text] [Related]
15. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon. Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362 [TBL] [Abstract][Full Text] [Related]
16. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561 [TBL] [Abstract][Full Text] [Related]
17. Regulation of HLA class II antigen expression: intracellular signaling molecules responsible for the regulation by IFN-gamma and cross-linking of Fc receptors in HL-60 cells. Ina Y; Koide Y; Nezu N; Yoshida TO J Immunol; 1987 Sep; 139(5):1711-7. PubMed ID: 3040858 [TBL] [Abstract][Full Text] [Related]
18. Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells. Staudt MR; Depass AL; Sarkar D; Fisher PB J Cell Physiol; 2009 Feb; 218(2):304-14. PubMed ID: 18844238 [TBL] [Abstract][Full Text] [Related]
19. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells. Maio M; Gulwani B; Morgano A; Ferrone S Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138 [TBL] [Abstract][Full Text] [Related]
20. In vitro differentiation and antigenic changes in human melanoma cell lines. Guarini L; Temponi M; Edwalds GM; Vita JR; Fisher PB; Ferrone S Cancer Immunol Immunother; 1989; 30(5):262-8. PubMed ID: 2624919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]